Skip to content

Use of Different Types of Local Anesthetics in Third Molar Removal Surgery

Evaluation and comparison of different types of local anesthetics in lower third molar surgery: a randomized triple-blind clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-2v92y82
Enrollment
69
Registered
2026-06-17
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Postoperative Pain

Interventions

During the preoperative appointment, data regarding sex, age, general health status, complete blood count, platelet count, international normalized ratio (INR), and fasting blood glucose levels will b
DFL®, Brazil), 4% articaine with epinephrine 1:100,000 (Articaine 100
DFL®, Brazil), or 4% articaine with epinephrine 1:200,000 (Articaine 200
DFL®, Brazil), using two 1.8 mL cartridges of anesthetic solution. A full-thickness triangular flap will be performed, followed by peripheral ostectomy and/or odontosection using a high-speed handpiec

Sponsors

Centro Universitário Christus - UNICHRISTUS
Lead Sponsor
Centro Universitário Christus - UNICHRISTUS
Collaborator

Eligibility

Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Healthy individuals (American Society of Anesthesiologists - ASA I); of both sexes; aged between 18 and 35 years; in need of removal of lower third molars; third molars that present, on panoramic radiography, similar patterns of root formation, position and degree of impaction when comparing the right and left sides of each volunteer

Exclusion criteria

Exclusion criteria: Smokers; pregnant or breastfeeding women; users of medications prior to surgery that may interact with the patient's pain (e.g. NSAIDs, corticosteroids, analgesics); wearers of orthodontic bands on mandibular second molars; signs of any preoperative inflammatory or infectious condition; systemic diseases; neurological disorders

Design outcomes

Primary

MeasureTime frame
An improvement in clinical parameters related to pain is expected. Data were collected one hour before the intervention and one week after the intervention

Secondary

MeasureTime frame
An improvement is expected in the reduction of rescue medication consumption, considering the time to first intake and the total amount used during the first 7 postoperative days. Hemodynamic parameters will also be evaluated, including heart rate, respiratory rate, oximetry, pulse, and body temperature. In addition, the impact on quality of life will be analyzed using the "Oral Health Impact Profile"-14 (OHIP-14) questionnaire, applied preoperatively, 24 hours, and 7 days after the surgical procedure

Countries

BR

Contacts

Public ContactEdson Cetira Filho

Centro Universitário Christus - UNICHRISTUS

edson.cetira@hotmail.com+5585997219653

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Jun 29, 2026